Lyell Immunopharma (LYEL) Amortizatization of Intangibles (2020 - 2025)
Lyell Immunopharma (LYEL) has disclosed Amortizatization of Intangibles for 6 consecutive years, with $1.1 million as the latest value for Q4 2025.
- Quarterly Amortizatization of Intangibles fell 64.25% to $1.1 million in Q4 2025 from the year-ago period, while the trailing twelve-month figure was $5.0 million through Dec 2025, down 66.22% year-over-year, with the annual reading at $5.0 million for FY2025, 66.22% down from the prior year.
- Amortizatization of Intangibles hit $1.1 million in Q4 2025 for Lyell Immunopharma, up from $1.0 million in the prior quarter.
- In the past five years, Amortizatization of Intangibles ranged from a high of $4.4 million in Q1 2024 to a low of -$552000.0 in Q3 2021.
- Historically, Amortizatization of Intangibles has averaged $1.4 million across 5 years, with a median of $1.2 million in 2022.
- Biggest five-year swings in Amortizatization of Intangibles: crashed 198.38% in 2021 and later soared 998.27% in 2023.
- Year by year, Amortizatization of Intangibles stood at -$467000.0 in 2021, then surged by 358.67% to $1.2 million in 2022, then surged by 180.13% to $3.4 million in 2023, then fell by 12.38% to $3.0 million in 2024, then tumbled by 64.25% to $1.1 million in 2025.
- Business Quant data shows Amortizatization of Intangibles for LYEL at $1.1 million in Q4 2025, $1.0 million in Q3 2025, and $1.2 million in Q2 2025.